Purdue Pharma $7.4 billion opioid settlement wins broad support from U.S. states
The $7.4 billion payment is intended to resolve claims that the drugmaker's pain medication OxyContin caused a nationwide opioid addiction crisis.
You are not logged in so some information on this page has been withheld. To see more, please log in.